The Market Reports

Index

1 Orphan Drugs Market Overview
1.1 Product Overview and Scope of Orphan Drugs
1.2 Orphan Drugs Segment by Type
1.2.1 Global Orphan Drugs Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Oncology
1.2.3 Gastrointestinal
1.2.4 Pulmonary
1.2.5 Neurology
1.2.6 Hematology
1.2.7 Cardio-vascular
1.2.8 Metabolic Disorders
1.2.9 Endocrinology
1.2.10 Infectious Diseases
1.2.11 Others
1.3 Orphan Drugs Segment by Application
1.3.1 Global Orphan Drugs Sales Comparison by Application: (2021-2027)
1.3.2 Hospital Pharmacies
1.3.3 Retail pharmacies
1.3.4 Others
1.4 Global Orphan Drugs Market Size Estimates and Forecasts
1.4.1 Global Orphan Drugs Revenue 2016-2027
1.4.2 Global Orphan Drugs Sales 2016-2027
1.4.3 Orphan Drugs Market Size by Region: 2016 Versus 2021 Versus 2027

2 Orphan Drugs Market Competition by Manufacturers
2.1 Global Orphan Drugs Sales Market Share by Manufacturers (2016-2021)
2.2 Global Orphan Drugs Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Orphan Drugs Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Orphan Drugs Manufacturing Sites, Area Served, Product Type
2.5 Orphan Drugs Market Competitive Situation and Trends
2.5.1 Orphan Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Orphan Drugs Players Market Share by Revenue
2.5.3 Global Orphan Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Orphan Drugs Retrospective Market Scenario by Region
3.1 Global Orphan Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Orphan Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Orphan Drugs Market Facts & Figures by Country
3.3.1 North America Orphan Drugs Sales by Country
3.3.2 North America Orphan Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Orphan Drugs Market Facts & Figures by Country
3.4.1 Europe Orphan Drugs Sales by Country
3.4.2 Europe Orphan Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Orphan Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Orphan Drugs Sales by Region
3.5.2 Asia Pacific Orphan Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Orphan Drugs Market Facts & Figures by Country
3.6.1 Latin America Orphan Drugs Sales by Country
3.6.2 Latin America Orphan Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Orphan Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Orphan Drugs Sales by Country
3.7.2 Middle East and Africa Orphan Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Orphan Drugs Historic Market Analysis by Type
4.1 Global Orphan Drugs Sales Market Share by Type (2016-2021)
4.2 Global Orphan Drugs Revenue Market Share by Type (2016-2021)
4.3 Global Orphan Drugs Price by Type (2016-2021)

5 Global Orphan Drugs Historic Market Analysis by Application
5.1 Global Orphan Drugs Sales Market Share by Application (2016-2021)
5.2 Global Orphan Drugs Revenue Market Share by Application (2016-2021)
5.3 Global Orphan Drugs Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Orphan Drugs Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Novartis Orphan Drugs Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Bristol-Myers Squibb Company
6.2.1 Bristol-Myers Squibb Company Corporation Information
6.2.2 Bristol-Myers Squibb Company Description and Business Overview
6.2.3 Bristol-Myers Squibb Company Orphan Drugs Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Bristol-Myers Squibb Company Orphan Drugs Product Portfolio
6.2.5 Bristol-Myers Squibb Company Recent Developments/Updates
6.3 Celgene
6.3.1 Celgene Corporation Information
6.3.2 Celgene Description and Business Overview
6.3.3 Celgene Orphan Drugs Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Celgene Orphan Drugs Product Portfolio
6.3.5 Celgene Recent Developments/Updates
6.4 F. Hoffmann-La Roche
6.4.1 F. Hoffmann-La Roche Corporation Information
6.4.2 F. Hoffmann-La Roche Description and Business Overview
6.4.3 F. Hoffmann-La Roche Orphan Drugs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 F. Hoffmann-La Roche Orphan Drugs Product Portfolio
6.4.5 F. Hoffmann-La Roche Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Orphan Drugs Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Pfizer Orphan Drugs Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Sanofi
6.6.1 Sanofi Corporation Information
6.6.2 Sanofi Description and Business Overview
6.6.3 Sanofi Orphan Drugs Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Sanofi Orphan Drugs Product Portfolio
6.6.5 Sanofi Recent Developments/Updates
6.7 Alexion Pharmaceuticals
6.6.1 Alexion Pharmaceuticals Corporation Information
6.6.2 Alexion Pharmaceuticals Description and Business Overview
6.6.3 Alexion Pharmaceuticals Orphan Drugs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Alexion Pharmaceuticals Orphan Drugs Product Portfolio
6.7.5 Alexion Pharmaceuticals Recent Developments/Updates
6.8 Eli Lilly and Company
6.8.1 Eli Lilly and Company Corporation Information
6.8.2 Eli Lilly and Company Description and Business Overview
6.8.3 Eli Lilly and Company Orphan Drugs Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Eli Lilly and Company Orphan Drugs Product Portfolio
6.8.5 Eli Lilly and Company Recent Developments/Updates
6.9 Novo Nordisk
6.9.1 Novo Nordisk Corporation Information
6.9.2 Novo Nordisk Description and Business Overview
6.9.3 Novo Nordisk Orphan Drugs Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Novo Nordisk Orphan Drugs Product Portfolio
6.9.5 Novo Nordisk Recent Developments/Updates
6.10 AstraZeneca
6.10.1 AstraZeneca Corporation Information
6.10.2 AstraZeneca Description and Business Overview
6.10.3 AstraZeneca Orphan Drugs Sales, Revenue and Gross Margin (2016-2021)
6.10.4 AstraZeneca Orphan Drugs Product Portfolio
6.10.5 AstraZeneca Recent Developments/Updates
6.11 Eisai
6.11.1 Eisai Corporation Information
6.11.2 Eisai Orphan Drugs Description and Business Overview
6.11.3 Eisai Orphan Drugs Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Eisai Orphan Drugs Product Portfolio
6.11.5 Eisai Recent Developments/Updates
6.12 Daiichi Sankyo Company
6.12.1 Daiichi Sankyo Company Corporation Information
6.12.2 Daiichi Sankyo Company Orphan Drugs Description and Business Overview
6.12.3 Daiichi Sankyo Company Orphan Drugs Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Daiichi Sankyo Company Orphan Drugs Product Portfolio
6.12.5 Daiichi Sankyo Company Recent Developments/Updates
6.13 Bayer
6.13.1 Bayer Corporation Information
6.13.2 Bayer Orphan Drugs Description and Business Overview
6.13.3 Bayer Orphan Drugs Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Bayer Orphan Drugs Product Portfolio
6.13.5 Bayer Recent Developments/Updates
6.14 GlaxoSmithKline
6.14.1 GlaxoSmithKline Corporation Information
6.14.2 GlaxoSmithKline Orphan Drugs Description and Business Overview
6.14.3 GlaxoSmithKline Orphan Drugs Sales, Revenue and Gross Margin (2016-2021)
6.14.4 GlaxoSmithKline Orphan Drugs Product Portfolio
6.14.5 GlaxoSmithKline Recent Developments/Updates
6.15 Merck & Co
6.15.1 Merck & Co Corporation Information
6.15.2 Merck & Co Orphan Drugs Description and Business Overview
6.15.3 Merck & Co Orphan Drugs Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Merck & Co Orphan Drugs Product Portfolio
6.15.5 Merck & Co Recent Developments/Updates
6.16 Johnson & Johnson
6.16.1 Johnson & Johnson Corporation Information
6.16.2 Johnson & Johnson Orphan Drugs Description and Business Overview
6.16.3 Johnson & Johnson Orphan Drugs Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Johnson & Johnson Orphan Drugs Product Portfolio
6.16.5 Johnson & Johnson Recent Developments/Updates
6.17 Biogen
6.17.1 Biogen Corporation Information
6.17.2 Biogen Orphan Drugs Description and Business Overview
6.17.3 Biogen Orphan Drugs Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Biogen Orphan Drugs Product Portfolio
6.17.5 Biogen Recent Developments/Updates
6.18 Takeda
6.18.1 Takeda Corporation Information
6.18.2 Takeda Orphan Drugs Description and Business Overview
6.18.3 Takeda Orphan Drugs Sales, Revenue and Gross Margin (2016-2021)
6.18.4 Takeda Orphan Drugs Product Portfolio
6.18.5 Takeda Recent Developments/Updates
6.19 Amgen
6.19.1 Amgen Corporation Information
6.19.2 Amgen Orphan Drugs Description and Business Overview
6.19.3 Amgen Orphan Drugs Sales, Revenue and Gross Margin (2016-2021)
6.19.4 Amgen Orphan Drugs Product Portfolio
6.19.5 Amgen Recent Developments/Updates

7 Orphan Drugs Manufacturing Cost Analysis
7.1 Orphan Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Orphan Drugs
7.4 Orphan Drugs Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Orphan Drugs Distributors List
8.3 Orphan Drugs Customers

9 Orphan Drugs Market Dynamics
9.1 Orphan Drugs Industry Trends
9.2 Orphan Drugs Growth Drivers
9.3 Orphan Drugs Market Challenges
9.4 Orphan Drugs Market Restraints

10 Global Market Forecast
10.1 Orphan Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Orphan Drugs by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Orphan Drugs by Type (2022-2027)
10.2 Orphan Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Orphan Drugs by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Orphan Drugs by Application (2022-2027)
10.3 Orphan Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Orphan Drugs by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Orphan Drugs by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Orphan Drugs Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Orphan Drugs Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Orphan Drugs Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Orphan Drugs Covered in This Study
Table 5. Global Orphan Drugs Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Orphan Drugs Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Orphan Drugs Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Orphan Drugs Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Orphan Drugs Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Orphan Drugs Manufacturing Sites and Area Served
Table 11. Manufacturers Orphan Drugs Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Orphan Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Orphan Drugs as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Orphan Drugs Sales by Region (2016-2021) & (K Units)
Table 16. Global Orphan Drugs Sales Market Share by Region (2016-2021)
Table 17. Global Orphan Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Orphan Drugs Sales by Country (2016-2021) & (K Units)
Table 19. North America Orphan Drugs Sales Market Share by Country (2016-2021)
Table 20. North America Orphan Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Orphan Drugs Revenue Market Share by Country (2016-2021)
Table 22. Europe Orphan Drugs Sales by Country (2016-2021) & (K Units)
Table 23. Europe Orphan Drugs Sales Market Share by Country (2016-2021)
Table 24. Europe Orphan Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Orphan Drugs Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Orphan Drugs Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Orphan Drugs Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Orphan Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Orphan Drugs Revenue Market Share by Region (2016-2021)
Table 30. Latin America Orphan Drugs Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Orphan Drugs Sales Market Share by Country (2016-2021)
Table 32. Latin America Orphan Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Orphan Drugs Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Orphan Drugs Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Orphan Drugs Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Orphan Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Orphan Drugs Revenue Market Share by Country (2016-2021)
Table 38. Global Orphan Drugs Sales (K Units) by Type (2016-2021)
Table 39. Global Orphan Drugs Sales Market Share by Type (2016-2021)
Table 40. Global Orphan Drugs Revenue (Million US$) by Type (2016-2021)
Table 41. Global Orphan Drugs Revenue Share by Type (2016-2021)
Table 42. Global Orphan Drugs Price (USD/Unit) by Type (2016-2021)
Table 43. Global Orphan Drugs Sales (K Units) by Application (2016-2021)
Table 44. Global Orphan Drugs Sales Market Share by Application (2016-2021)
Table 45. Global Orphan Drugs Revenue (Million US$) by Application (2016-2021)
Table 46. Global Orphan Drugs Revenue Share by Application (2016-2021)
Table 47. Global Orphan Drugs Price (USD/Unit) by Application (2016-2021)
Table 48. Novartis Corporation Information
Table 49. Novartis Description and Business Overview
Table 50. Novartis Orphan Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Novartis Orphan Drugs Product
Table 52. Novartis Recent Developments/Updates
Table 53. Bristol-Myers Squibb Company Corporation Information
Table 54. Bristol-Myers Squibb Company Description and Business Overview
Table 55. Bristol-Myers Squibb Company Orphan Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Bristol-Myers Squibb Company Orphan Drugs Product
Table 57. Bristol-Myers Squibb Company Recent Developments/Updates
Table 58. Celgene Corporation Information
Table 59. Celgene Description and Business Overview
Table 60. Celgene Orphan Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Celgene Orphan Drugs Product
Table 62. Celgene Recent Developments/Updates
Table 63. F. Hoffmann-La Roche Corporation Information
Table 64. F. Hoffmann-La Roche Description and Business Overview
Table 65. F. Hoffmann-La Roche Orphan Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. F. Hoffmann-La Roche Orphan Drugs Product
Table 67. F. Hoffmann-La Roche Recent Developments/Updates
Table 68. Pfizer Corporation Information
Table 69. Pfizer Description and Business Overview
Table 70. Pfizer Orphan Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Pfizer Orphan Drugs Product
Table 72. Pfizer Recent Developments/Updates
Table 73. Sanofi Corporation Information
Table 74. Sanofi Description and Business Overview
Table 75. Sanofi Orphan Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Sanofi Orphan Drugs Product
Table 77. Sanofi Recent Developments/Updates
Table 78. Alexion Pharmaceuticals Corporation Information
Table 79. Alexion Pharmaceuticals Description and Business Overview
Table 80. Alexion Pharmaceuticals Orphan Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Alexion Pharmaceuticals Orphan Drugs Product
Table 82. Alexion Pharmaceuticals Recent Developments/Updates
Table 83. Eli Lilly and Company Corporation Information
Table 84. Eli Lilly and Company Description and Business Overview
Table 85. Eli Lilly and Company Orphan Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. Eli Lilly and Company Orphan Drugs Product
Table 87. Eli Lilly and Company Recent Developments/Updates
Table 88. Novo Nordisk Corporation Information
Table 89. Novo Nordisk Description and Business Overview
Table 90. Novo Nordisk Orphan Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. Novo Nordisk Orphan Drugs Product
Table 92. Novo Nordisk Recent Developments/Updates
Table 93. AstraZeneca Corporation Information
Table 94. AstraZeneca Description and Business Overview
Table 95. AstraZeneca Orphan Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. AstraZeneca Orphan Drugs Product
Table 97. AstraZeneca Recent Developments/Updates
Table 98. Eisai Corporation Information
Table 99. Eisai Description and Business Overview
Table 100. Eisai Orphan Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 101. Eisai Orphan Drugs Product
Table 102. Eisai Recent Developments/Updates
Table 103. Daiichi Sankyo Company Corporation Information
Table 104. Daiichi Sankyo Company Description and Business Overview
Table 105. Daiichi Sankyo Company Orphan Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 106. Daiichi Sankyo Company Orphan Drugs Product
Table 107. Daiichi Sankyo Company Recent Developments/Updates
Table 108. Bayer Corporation Information
Table 109. Bayer Description and Business Overview
Table 110. Bayer Orphan Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 111. Bayer Orphan Drugs Product
Table 112. Bayer Recent Developments/Updates
Table 113. GlaxoSmithKline Corporation Information
Table 114. GlaxoSmithKline Description and Business Overview
Table 115. GlaxoSmithKline Orphan Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 116. GlaxoSmithKline Orphan Drugs Product
Table 117. GlaxoSmithKline Recent Developments/Updates
Table 118. Merck & Co Corporation Information
Table 119. Merck & Co Description and Business Overview
Table 120. Merck & Co Orphan Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 121. Merck & Co Orphan Drugs Product
Table 122. Merck & Co Recent Developments/Updates
Table 123. Johnson & Johnson Corporation Information
Table 124. Johnson & Johnson Description and Business Overview
Table 125. Johnson & Johnson Orphan Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 126. Johnson & Johnson Orphan Drugs Product
Table 127. Johnson & Johnson Recent Developments/Updates
Table 128. Biogen Corporation Information
Table 129. Biogen Description and Business Overview
Table 130. Biogen Orphan Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 131. Biogen Orphan Drugs Product
Table 132. Biogen Recent Developments/Updates
Table 133. Takeda Corporation Information
Table 134. Takeda Description and Business Overview
Table 135. Takeda Orphan Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 136. Takeda Orphan Drugs Product
Table 137. Takeda Recent Developments/Updates
Table 138. Amgen Corporation Information
Table 139. Amgen Description and Business Overview
Table 140. Amgen Orphan Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 141. Amgen Orphan Drugs Product
Table 142. Amgen Recent Developments/Updates
Table 143. Production Base and Market Concentration Rate of Raw Material
Table 144. Key Suppliers of Raw Materials
Table 145. Orphan Drugs Distributors List
Table 146. Orphan Drugs Customers List
Table 147. Orphan Drugs Market Trends
Table 148. Orphan Drugs Growth Drivers
Table 149. Orphan Drugs Market Challenges
Table 150. Orphan Drugs Market Restraints
Table 151. Global Orphan Drugs Sales Forecast by Type (2022-2027) & (K Units)
Table 152. Global Orphan Drugs Sales Market Share Forecast by Type (2022-2027)
Table 153. Global Orphan Drugs Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 154. Global Orphan Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 155. Global Orphan Drugs Sales Forecast by Application (2022-2027) & (K Units)
Table 156. Global Orphan Drugs Sales Market Share Forecast by Application (2022-2027)
Table 157. Global Orphan Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 158. Global Orphan Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 159. Global Orphan Drugs Sales Forecast by Region (2022-2027) & (K Units)
Table 160. Global Orphan Drugs Sales Market Share Forecast by Region (2022-2027)
Table 161. Global Orphan Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 162. Global Orphan Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Orphan Drugs
Figure 2. Global Orphan Drugs Market Share by Type in 2020 & 2027
Figure 3. Oncology Product Picture
Figure 4. Gastrointestinal Product Picture
Figure 5. Pulmonary Product Picture
Figure 6. Neurology Product Picture
Figure 7. Hematology Product Picture
Figure 8. Cardio-vascular Product Picture
Figure 9. Metabolic Disorders Product Picture
Figure 10. Endocrinology Product Picture
Figure 11. Infectious Diseases Product Picture
Figure 12. Others Product Picture
Figure 13. Global Orphan Drugs Market Share by Application in 2020 & 2027
Figure 14. Hospital Pharmacies
Figure 15. Retail pharmacies
Figure 16. Others
Figure 17. Global Orphan Drugs Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 18. Global Orphan Drugs Market Size 2016-2027 (US$ Million)
Figure 19. Global Orphan Drugs Sales 2016-2027 (K Units)
Figure 20. Global Orphan Drugs Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 21. Orphan Drugs Sales Share by Manufacturers in 2020
Figure 22. Global Orphan Drugs Revenue Share by Manufacturers in 2020
Figure 23. The Global 5 and 10 Largest Orphan Drugs Players: Market Share by Revenue in 2020
Figure 24. Orphan Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 25. Global Orphan Drugs Sales Market Share by Region (2016-2021)
Figure 26. Global Orphan Drugs Sales Market Share by Region in 2020
Figure 27. Global Orphan Drugs Revenue Market Share by Region (2016-2021)
Figure 28. Global Orphan Drugs Revenue Market Share by Region in 2020
Figure 29. U.S. Orphan Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Canada Orphan Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Germany Orphan Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. France Orphan Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. U.K. Orphan Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Italy Orphan Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Russia Orphan Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. China Orphan Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Japan Orphan Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. South Korea Orphan Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. India Orphan Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Australia Orphan Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Taiwan Orphan Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Indonesia Orphan Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Thailand Orphan Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Malaysia Orphan Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Philippines Orphan Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Vietnam Orphan Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Mexico Orphan Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Brazil Orphan Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Argentina Orphan Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. Turkey Orphan Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. Saudi Arabia Orphan Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. U.A.E Orphan Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. Sales Market Share of Orphan Drugs by Type (2016-2021)
Figure 54. Sales Market Share of Orphan Drugs by Application (2016-2021)
Figure 55. Sales Market Share of Orphan Drugs by Application in 2020
Figure 56. Revenue Share of Orphan Drugs by Application (2016-2021)
Figure 57. Revenue Share of Orphan Drugs by Application in 2020
Figure 58. Manufacturing Cost Structure of Orphan Drugs
Figure 59. Manufacturing Process Analysis of Orphan Drugs
Figure 60. Orphan Drugs Industrial Chain Analysis
Figure 61. Channels of Distribution
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed